Denumire dispozitiv | Tip | Clasa | Cod înregistrare | Producator | Reprezentant autorizat | Data | Observații |
---|---|---|---|---|---|---|---|
DISCURI ANTIBIOGRAMA | Susceptibility Discs® DOXYCYCLINE, DO, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_29 | SC TODY LABORATORIES INT. SRL | - | 24-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® ERTAPENEM, ETP, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_30 | SC TODY LABORATORIES INT. SRL | - | 24-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® ERITHROMYCIN, E, 15 mcg | IN VITRO ALTELE | RO_IVD_227_783_31 | SC TODY LABORATORIES INT. SRL | - | 24-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® FAROPENEM, FAR, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_32 | SC TODY LABORATORIES INT. SRL | - | 24-07-2020 | |
DISCURI ANTIFUNGIGRAMA | Susceptibility Discs® FLUCONAZOLE, FLC, 25 mcg | IN VITRO ALTELE | RO_IVD_227_783_33 | SC TODY LABORATORIES INT. SRL | - | 24-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® GATIFLOXACIN, GAT, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_34 | SC TODY LABORATORIES INT. SRL | - | 24-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® GEMIFLOXACIN, GEM, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_35 | SC TODY LABORATORIES INT. SRL | - | 24-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® GENTAMICIN, GEN, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_36 | SC TODY LABORATORIES INT. SRL | - | 24-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® GENTAMICIN, HLG, 120 mcg | IN VITRO ALTELE | RO_IVD_227_783_37 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® IMIPENEM, IPM, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_38 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® KANAMYCIN, K, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_39 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® LEVOFLOXACIN, LE, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_40 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® LINEZOLID, LZ, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_41 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® LOMEFLOXACIN, LOM, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_42 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® MEROPENEM, MRP, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_43 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® MINOCYCLINE, MI, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_44 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® MOXIFLOXACIN, MO, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_45 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® NALIDIXIC ACID, NA, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_46 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® NETILLIN (Netimicin Sulphate), NET, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_47 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® NITROFURANTOIN, NIT, 300 mcg | IN VITRO ALTELE | RO_IVD_227_783_48 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® NORFLOXACIN, NX, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_49 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® OFLOXACIN, OF, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_50 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® OXACILLIN, OX, 1 mcg | IN VITRO ALTELE | RO_IVD_227_783_51 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® PEFLOXACIN, PF, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_52 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® PENICILLIN-G, P, 10 units | IN VITRO ALTELE | RO_IVD_227_783_53 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® PIPERACILLIN, PI, 100 mcg | IN VITRO ALTELE | RO_IVD_227_783_54 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® PIPERACILLIN/TAZOBACTUM, PIT, 100/10 mcg | IN VITRO ALTELE | RO_IVD_227_783_55 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® POLYMYXIN-B, PB, 300 units | IN VITRO ALTELE | RO_IVD_227_783_56 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® PRULIFLOXACIN (ULIFLOXACIN), PRU, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_57 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® RIFAMPICIN, RIF, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_58 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® SPARFLOXACIN, SPX, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_59 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® SPECTINOMYCIN, SPT, 100 mcg | IN VITRO ALTELE | RO_IVD_227_783_60 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® STREPTOMYCIN, S, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_61 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® STREPTOMYCIN, HLS, 300 mcg | IN VITRO ALTELE | RO_IVD_227_783_62 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® TEICOPLANIN, TEI, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_63 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® TETRACYCLINE, TE, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_64 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® TICARCILLIN, TI, 75 mcg | IN VITRO ALTELE | RO_IVD_227_783_65 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® TICARCILLIN/CLAVULANIC ACID, TCC, 75/10 mcg | IN VITRO ALTELE | RO_IVD_227_783_66 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® TOBRAMYCIN, TOB, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_67 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® TRIMETHOPRIM, TR, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_68 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® VANCOMYCIN, VA, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_69 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIFUNGIGRAMA | Susceptibility Discs® VORICONAZOLE, VRC, 1 mcg | IN VITRO ALTELE | RO_IVD_227_783_70 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® AMOXICILLIN, AMX, 10 mcg | IN VITRO ALTELE | RO_IVD_227_783_71 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® AMOXICILLIN, AMX, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_72 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® CEFADROXIL, CFR, 30 mcg | IN VITRO ALTELE | RO_IVD_227_783_73 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
DISCURI ANTIBIOGRAMA | Susceptibility Discs® CLOXACILLIN, COX, 5 mcg | IN VITRO ALTELE | RO_IVD_227_783_74 | SC TODY LABORATORIES INT. SRL | - | 27-07-2020 | |
SUPOZITOARE CU GLICERINA, PENTRU COPII | FARMACIA DONA | CLASA I | RO_I_190_499_03 | SC EMINVEST PHARMACEUTICALS SRL | - | 30-07-2020 | |
SUPOZITOARE CU GLICERINA, PENTRU ADULTI | FARMACIA DONA | CLASA I | RO_I_190_499_04 | SC EMINVEST PHARMACEUTICALS SRL | - | 30-07-2020 | |
CORONAVIRUS (SARS-COV-2) ANTICORPI TOTALI (IgM/IgG) ELISA | IN VITRO ALTELE | RO_IVD_227_784_01 | SC TODY LABORATORIES INT. SRL | - | 30-07-2020 | ||
MASCA FACIALA DE UZ MEDICAL, M01 | II | CLASA I | RO_I_324_785_01 | SHENZHEN TOPTELE TECHNOLOGY CO. LTD | SC DANTE INTERNATIONAL S.A. | 30-07-2020 |
*Conform art. 31 alin. (2) din HG nr 54/2009, art. 30 din HG nr. 798/2003 şi art. 30 din HG nr. 55/2009